The Ibex holds the 8,500 points immune to the delay in vaccination against Covid

The Ibex 35 has closed flat, at 8,525 points, after learning that the US FDA (Food and Drug Administration) has asked to pause the use of the Johnson & Johnson vaccine due to possibly related blood clots cases. In Europe, the American multinational, which distributes the vaccine through its Janssen subsidiary, has decided to "delay the launch in Europe" until the situation is clarified.